Schistosomiasis: clinical spectrum of the disease and response to oxamniquine treatment in chronic infections
García Goyco, C.; Torres Borges, A.
Boletin de la Asociacion Medica de Puerto Rico 74(4): 126-128
1982
ISSN/ISBN: 0004-4849 PMID: 6960899 Document Number: 701383
A study was made of 47 patients in Puerto Rico with chronic Schistosoma mansoni infection. 39 had the intestinal form (21 were asymptomatic) and 8 had the hepatosplenic form (4 were asymptomatic). Oxamniquine (15 mg/kg for adults and 20 mg/kg for children) cured all 16 patients with faecal egg counts less than 100 epg and 6 of 7 with counts more than 100 epg.
Document emailed within 1 workday
Related Documents
Bassily, S.; Farid, Z.; Higashi, G.I.; Watten, R.H. 1978: Treatment of complicated schistosomiasis mansoni with oxamniquine American Journal of Tropical Medicine and Hygiene 27(6): 1284-1286de Clarke, V. 1980: Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia Revista do Instituto de Medicina Tropical de Sao Paulo 22(1 Suppl 4): 28-31 144-7
García Goyco, C.; Nazario-López, H.; Ruiz-Tiben, E.; Vázquez, G.; Borges, T.; Nash, T.E. 1997: The efficacy of oxamniquine in acute schistosomiasis: a clinical analysis of 28 treated patients Boletin de la Asociacion Medica de Puerto Rico 89(4-6): 63-69
Guitti, J.C.; Gordan, L.N.; Baldy, J.L. 1993: Cardiac arrhythmia with oral oxamniquine use in the schistosomiasis mansoni treatment Revista do Instituto de Medicina Tropical de Sao Paulo 35(6): 585-587
Creasey, A.M.; Taylor, P.; Thomas, J.E. 1986: Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren Central African Journal of Medicine 32(7): 165-167
Lambertucci, J.R.; Pedroso, E.R.; de Souza, D.W.; de Lima, D.P.; Neves, J.; Salazar, H.M.; Marinho, R.P.; da Costa Rocha, M.O.; Coelho, P.M.; de Lima Costa, M.F.; Greco, D.B. 1980: Therapeutic efficacy of oral oxamniquine in the toxemic form of schistosomiasis mansoni: treatment of eleven individuals from two families, and experimental study American Journal of Tropical Medicine and Hygiene 29(1): 50-53
Kolkman, J.J.; Mensink, P.B.F.; van Petersen, A.S.; Huisman, A.B.; Geelkerken, R.H. 2004: Clinical approach to chronic gastrointestinal ischaemia: from 'intestinal angina' to the spectrum of chronic splanchnic disease Scandinavian Journal of Gastroenterology. Supplement 2004(241): 9-16
Pitchford, R.J.; Lewis, M. 1978: Oxamniquine in the treatment of various schistosome infections in South Africa South African Medical Journal 53(17): 677-680
Korolkovas, A.; Coelho, P.M.; Oliveira e Rocha, M.; Pereira, L.H.; Barbosa, M.A. 1980: Chemoprophylactic properties of oxamniquine embonate in experimental schistosomiasis Revista do Instituto de Medicina Tropical de Sao Paulo 22(3): 144-148
Schoenfield, L.J. 1976: Clinical spectrum of chronic active liver disease (CALD) Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 28(3): 235-243
Da Cunha, A.S. 1982: Therapeutic evaluation of oxamniquine in schistosomiasis mansoni by the oogram method with biopsy of rectal mucosa Revista do Instituto de Medicina Tropical de Sao Paulo 24(2): 88-94
da Silva, L.C.; Sette Júnior, H.; Christo, C.; Sette, P.C.; Kaye, B. 1980: Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose Revista do Instituto de Medicina Tropical de Sao Paulo 22(1 Suppl 4): 58-64 175-81
Andiman, W.A. 1986: Lyme disease: epidemiology, etiology, clinical spectrum, diagnosis, and treatment Advances in Pediatric Infectious Diseases 1: 163-186
Moskaliuk, V.D.; Andrushchak, M.O.; Andreychyn, Y.M.; Balanyk, I.V.; Rudan, I.V.; Andrushchak, A.V.; Berezova, M.S. 2018: Clinical-laboratory analysis of hiv-infections at a chronic disease of kidneys Wiadomosci Lekarskie 71(6): 1182-1185
Usman, M.; Syed, N.N.; Kakepoto, G.N.; Adil, S.N.; Khurshid, M. 2007: Chronic phase chronic myeloid leukemia: response of imatinib mesylate and significance of Sokal score, age and disease duration in predicting the hematological and cytogenetic response Journal of the Association of Physicians of India 55: 103-107
Deorari, A.K.; Broor, S.; Maitreyi, R.S.; Agarwal, D.; Kumar, H.; Paul, V.K.; Singh, M. 2000: Incidence, clinical spectrum, and outcome of intrauterine infections in neonates Journal of Tropical Pediatrics 46(3): 155-159
Suanprasert, N.; Hanchaiphiboolkul, S. 2017: Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Journal of the Medical Association of Thailand 100(3): 262-269
Anar, C.; Bicmen, C.; Yapicioglu, S.; Unsal, I.; Halilcolar, H.; Yilmaz, U. 2010: Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease New Microbiologica 33(2): 117-127
Kazemi, M.; Gumpert, G.; Marks, M.I. 1974: Clinical spectrum and carrier state of nontyphoidal salmonella infections in infants and children Canadian Medical Association Journal 110(11): 1253-1257
Chlebicki, M.P.; Oh, H.M.L. 2004: Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum Annals of the Academy of Medicine Singapore 33(3): 302-306